Snehlata Kumari
37 Kent Street
Woolloongabba, QLD 4102, Australia
Woolloongabba, QLD 4102, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Noninvasive in vivo imaging of NF-κB activation predicts immunotherapy response in solid tumors.
Journal: Npj imaging
Published: October 22, 2025
Integrating 12 Spatial and Single Cell Technologies to Characterise Tumour Neighbourhoods and Cellular Interactions in three Skin Cancer Types.
Journal: bioRxiv : the preprint server for biology
Published: August 06, 2025
Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer.
Journal: British journal of cancer
Published: July 24, 2025
Coordinated Development of Immune Cell Populations in Vascularized Skin Organoids from Human Induced Pluripotent Stem Cells.
Journal: Advanced healthcare materials
Published: April 28, 2025
Checkpoint Kinase 1 Inhibitor Combined with Low Dose Hydroxyurea Promotes ATM-Activated NF-κB-Dependent Pro-Inflammatory Chemokine Expression in Melanomas.
Journal: Cancers
Published: April 04, 2025
The Involvement of IL-34 in Inflammatory and Malignant Skin Diseases.
Journal: The Journal of investigative dermatology
Published: January 29, 2025
Skin immunity and inflammation: cellular interactions and communication.
Journal: Clinical & translational immunology
Published: December 02, 2024
Dysregulation in keratinocytes drives systemic lupus erythematosus onset.
Journal: Cellular & molecular immunology
Published: May 31, 2024
ZBP1 causes inflammation by inducing RIPK3-mediated necroptosis and RIPK1 kinase activity-independent apoptosis.
Journal: Cell death and differentiation
Published: March 04, 2024
Celebrating 100 years of Immunology & Cell Biology - a special focus on the field of tumor immunology in Australia.
Journal: Immunology and cell biology
Published: September 11, 2023
Last Updated: 09/26/2026